IRIDEX Corporation (IRIX)
Makes laser systems that surgeons use to treat eye diseases like glaucoma and diabetic retinopathy.
$0.88-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-31.2%
The outlook
IRIX is trading near its 52-week low, well below both its 50- and 200-day moving averages. Analyst sentiment leans bearish overall, though the average price target sits roughly 212% above the current price, suggesting a wide gap between current levels and where some analysts see fair value. The stock shows minimal upward momentum in its recent trend.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +212% vs current price
Market cap
$15.3M
52-wk high
$1.65
52-wk low
$0.87
50-day avg
$1.08
200-day avg
$1.14
Trailing P/E
—